Russell Trigonis

ORCID: 0000-0002-9700-6796
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 and healthcare impacts
  • Thermal Regulation in Medicine
  • Sepsis Diagnosis and Treatment
  • Antibiotic Use and Resistance
  • Long-Term Effects of COVID-19
  • Mechanical Circulatory Support Devices
  • Emergency and Acute Care Studies
  • Disaster Response and Management
  • Cardiac Arrest and Resuscitation
  • Pneumonia and Respiratory Infections
  • Potassium and Related Disorders
  • Pharmaceutical studies and practices
  • Electrolyte and hormonal disorders
  • Renal function and acid-base balance
  • Heparin-Induced Thrombocytopenia and Thrombosis

Indiana University – Purdue University Indianapolis
2020-2021

Indiana University School of Medicine
2020-2021

Virginia Tech
2016

One of the defining features novel coronavirus disease 2019 infection has been high rates venous thromboses. The present study aimed to describe prevalence thromboembolism in critically ill patients receiving different regimens prophylactic anticoagulation.Single-center retrospective review using data from with confirmed severe acute respiratory syndrome 2 requiring intubation.Tertiary-care center Indianapolis, IN, United States.Patients hospitalized at international units Health Methodist...

10.1097/ccm.0000000000004472 article EN Critical Care Medicine 2020-06-26

The rate of bacterial coinfection with SARS-CoV-2 is poorly defined. decision to administer antibiotics early in the course infection depends on likelihood coinfection.We performed a retrospective chart review all patients admitted through emergency department confirmed over 6-week period large healthcare system United States. Blood and respiratory culture results were abstracted adjudicated by multiple authors. primary outcome was bacteremia. We secondarily looked define clinical or...

10.1002/jmv.26795 article EN Journal of Medical Virology 2021-01-15

Abstract Background Patients with COVID‐19 can present to the emergency department (ED) at any point during spectrum of illness, making it difficult predict what level care patient will ultimately require. Admission a ward bed, which is subsequently upgraded within hours an intensive unit (ICU) represents inability appropriately patient's course illness. Predicting patients require ICU 24 would allow admissions be managed more appropriately. Methods This was retrospective study adults...

10.1111/acem.14245 article EN Academic Emergency Medicine 2021-03-06

ABSTRACT INTRODUCTION Hypoxemia in Severe Acute Respiratory Syndrome due to Novel Coronavirus of 2019 (SARS-CoV-2) is mediated by severe inflammation that may be mitigated corticosteroids. We evaluated pattern and effects corticosteroid use these patients during an early surge the pandemic. METHODS Observational study 136 SARS-CoV-2 admitted Intensive care Unit between March 1 April 27, 2020 at a tertiary hospital Indianapolis, USA. Statistical comparison cohorts dosing analysis was done....

10.1101/2020.07.29.20164277 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-30

Rahman, Omar; Trigonis, Russell; Craft, Mitchell; Kruer, Rachel; Miller, Emily; Terry, Colin; Persaud, Sarah; Kapoor, Rajat Author Information

10.1097/01.ccm.0000726984.48127.c5 article EN Critical Care Medicine 2020-12-11

Abstract Background The SARS-CoV-2 pandemic has caused over 400,000 deaths worldwide thus far, and poses therapeutic challenges for millions of patients. There is currently no treatment infection approved by the United States Food Drug Administration. Multiple agents have been used off-label to treat based on small observational cohorts in vitro data. Here we present experience a large academic medical center treating infection. Methods We performed retrospective cohort study patients...

10.1093/ofid/ofaa439.741 article EN cc-by-nc-nd Open Forum Infectious Diseases 2020-10-01
Coming Soon ...